350 related articles for article (PubMed ID: 8644896)
1. Assessment of the role of naturally acquired antibody levels to Plasmodium falciparum merozoite surface protein-1 in protecting Papua New Guinean children from malaria morbidity.
al-Yaman F; Genton B; Kramer KJ; Chang SP; Hui GS; Baisor M; Alpers MP
Am J Trop Med Hyg; 1996 May; 54(5):443-8. PubMed ID: 8644896
[TBL] [Abstract][Full Text] [Related]
2. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
Chang SP; Case SE; Gosnell WL; Hashimoto A; Kramer KJ; Tam LQ; Hashiro CQ; Nikaido CM; Gibson HL; Lee-Ng CT; Barr PJ; Yokota BT; Hut GS
Infect Immun; 1996 Jan; 64(1):253-61. PubMed ID: 8557348
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the role of the humoral response to Plasmodium falciparum MSP2 compared to RESA and SPf66 in protecting Papua New Guinean children from clinical malaria.
al-Yaman F; Genton B; Anders R; Taraika J; Ginny M; Mellor S; Alpers MP
Parasite Immunol; 1995 Sep; 17(9):493-501. PubMed ID: 8552419
[TBL] [Abstract][Full Text] [Related]
4. Naturally acquired antibodies against the major merozoite surface coat protein (MSP-1) of Plasmodium falciparum acquired by residents in an endemic area of Colombia.
Terrientes ZI; Kramer K; Herrera MA; Chang SP
Mem Inst Oswaldo Cruz; 1994; 89 Suppl 2():55-61. PubMed ID: 7565133
[TBL] [Abstract][Full Text] [Related]
5. Acquired antibody levels to Plasmodium falciparum merozoite surface antigen 1 in residents of a highly endemic area of Papua New Guinea.
al-Yaman F; Genton B; Kramer KJ; Taraika J; Chang SP; Hui GS; Alpers MP
Trans R Soc Trop Med Hyg; 1995; 89(5):555-9. PubMed ID: 8560539
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal investigation of IgG and IgM antibody responses to the merozoite surface protein-1 19-kiloDalton domain of Plasmodium falciparum in pregnant women and infants: associations with febrile illness, parasitemia, and anemia.
Branch OH; Udhayakumar V; Hightower AW; Oloo AJ; Hawley WA; Nahlen BL; Bloland PB; Kaslow DC; Lal AA
Am J Trop Med Hyg; 1998 Feb; 58(2):211-9. PubMed ID: 9502606
[TBL] [Abstract][Full Text] [Related]
7. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
Guevara Patiño JA; Holder AA; McBride JS; Blackman MJ
J Exp Med; 1997 Nov; 186(10):1689-99. PubMed ID: 9362529
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to the Plasmodium falciparum Proteins MSPDBL1 and MSPDBL2 Opsonize Merozoites, Inhibit Parasite Growth, and Predict Protection From Clinical Malaria.
Chiu CY; Hodder AN; Lin CS; Hill DL; Li Wai Suen CS; Schofield L; Siba PM; Mueller I; Cowman AF; Hansen DS
J Infect Dis; 2015 Aug; 212(3):406-15. PubMed ID: 25646353
[TBL] [Abstract][Full Text] [Related]
9. Differential antibody recognition of four allelic variants of the merozoite surface protein-2 (MSP-2) of Plasmodium falciparum.
Tonhosolo R; Wunderlich G; Ferreira MU
J Eukaryot Microbiol; 2001; 48(5):556-64. PubMed ID: 11596920
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G antibodies to merozoite surface antigens are associated with recovery from chloroquine-resistant Plasmodium falciparum in Gambian children.
Pinder M; Sutherland CJ; Sisay-Joof F; Ismaili J; McCall MB; Ord R; Hallett R; Holder AA; Milligan P
Infect Immun; 2006 May; 74(5):2887-93. PubMed ID: 16622227
[TBL] [Abstract][Full Text] [Related]
11. Relationship between humoral response to Plasmodium falciparum merozoite surface antigen-2 and malaria morbidity in a highly endemic area of Papua New Guinea.
al-Yaman F; Genton B; Anders RF; Falk M; Triglia T; Lewis D; Hii J; Beck HP; Alpers MP
Am J Trop Med Hyg; 1994 Nov; 51(5):593-602. PubMed ID: 7985752
[TBL] [Abstract][Full Text] [Related]
12. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis.
Fowkes FJ; Richards JS; Simpson JA; Beeson JG
PLoS Med; 2010 Jan; 7(1):e1000218. PubMed ID: 20098724
[TBL] [Abstract][Full Text] [Related]
13. Temporal variations in immune responses to conserved regions of Plasmodium falciparum merozoite surface proteins related to the severity of a prior malaria episode in Gabonese children.
Köhler C; Tebo AE; Dubois B; Deloron P; Kremsner PG; Luty AJ;
Trans R Soc Trop Med Hyg; 2003; 97(4):455-61. PubMed ID: 15259482
[TBL] [Abstract][Full Text] [Related]
14. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
15. Humoral response to defined Plasmodium falciparum antigens in cerebral and uncomplicated malaria and their relationship to parasite genotype.
Al-Yaman F; Genton B; Reeder JC; Mokela D; Anders RF; Alpers MP
Am J Trop Med Hyg; 1997 Apr; 56(4):430-5. PubMed ID: 9158053
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study of type-specific antibody responses to Plasmodium falciparum merozoite surface protein-1 in an area of unstable malaria in Sudan.
Cavanagh DR; Elhassan IM; Roper C; Robinson VJ; Giha H; Holder AA; Hviid L; Theander TG; Arnot DE; McBride JS
J Immunol; 1998 Jul; 161(1):347-59. PubMed ID: 9647243
[TBL] [Abstract][Full Text] [Related]
17. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
18. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1.
Egan AF; Morris J; Barnish G; Allen S; Greenwood BM; Kaslow DC; Holder AA; Riley EM
J Infect Dis; 1996 Mar; 173(3):765-9. PubMed ID: 8627050
[TBL] [Abstract][Full Text] [Related]
19. High levels of serum antibodies to merozoite surface protein 2 of Plasmodium falciparum are associated with reduced risk of clinical malaria in coastal Kenya.
Polley SD; Conway DJ; Cavanagh DR; McBride JS; Lowe BS; Williams TN; Mwangi TW; Marsh K
Vaccine; 2006 May; 24(19):4233-46. PubMed ID: 16111789
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent IgG subclass responses to Plasmodium falciparum EBA-175 are differentially associated with incidence of malaria in Mozambican children.
Dobaño C; Quelhas D; Quintó L; Puyol L; Serra-Casas E; Mayor A; Nhampossa T; Macete E; Aide P; Mandomando I; Sanz S; Puniya SK; Singh B; Gupta P; Bhattacharya A; Chauhan VS; Aponte JJ; Chitnis CE; Alonso PL; Menéndez C
Clin Vaccine Immunol; 2012 Feb; 19(2):157-66. PubMed ID: 22169088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
